MARGARET EMBRY: Open Payments
NPI 1386843407 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,215 in 98 payments from 23 companies in 2025. Trend: 2023 $1,098 · 2024 $1,213 · 2025 $2,215
Food & beverage: $2,215
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 7 | $301 |
| Corcept Therapeutics | 11 | $223 |
| Novo Nordisk Inc | 7 | $216 |
| Abbott Laboratories | 8 | $209 |
| Xeris Pharmaceuticals, Inc. | 11 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $141 |
| Insulet Corporation | 4 | $133 |
| Medtronic, Inc. | 4 | $130 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $112 |
| Amgen Inc. | 4 | $75 |
Products named: TWIIST, Korlym, RECORLEV, Ozempic, JARDIANCE, Omnipod, MINIMED 780G, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
